Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRB2 | P62993 | 1/20 | 0.51 |
| ▸ | CAPN1 | P07384 | 6/20 | 0.48 |
| ▸ | RAMP3 | O60896 | 6/20 | 0.43 |
| ▸ | CALCR | P30988 | 6/20 | 0.43 |
| ▸ | CTSB | P07858 | 1/20 | 0.42 |
| ▸ | CMA1 | P23946 | 1/20 | 0.41 |
| ▸ | XIAP | P98170 | 1/20 | 0.41 |
| ▸ | ACE | P12821 | 2/20 | 0.41 |
| ▸ | REN | P00797 | 1/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.40 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.40 |
| ▸ | BDKRB2 | P30411 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29547288 | 0.91 | GRB2 (0.48) | GRB2CAPN1RAMP3CALCRCMA1 | |
| SCHEMBL29546551 | 0.91 | GRB2 (0.48) | GRB2CAPN1RAMP3CALCRCMA1 | |
| SCHEMBL29471808 | 0.90 | GRB2 (0.48) | GRB2CAPN1RAMP3CALCRCTSB | |
| SCHEMBL29641846 | 0.85 | GRB2 (0.51) | GRB2CAPN1CTSBCMA1XIAP | |
| SCHEMBL31307226 | 0.84 | RAMP3 (0.47) | RAMP3CALCR | |
| SCHEMBL29776901 | 0.84 | GRB2 (0.53) | GRB2CAPN1CTSBXIAPOPRM1 | |
| SCHEMBL29511963 | 0.84 | ACE (0.46) | GRB2CAPN1CMA1XIAPACE | |
| SCHEMBL31410827 | 0.83 | RAMP3 (0.48) | RAMP3CALCROPRM1OPRD1 | |
| SCHEMBL31696320 | 0.83 | CTSD (0.45) | GRB2CAPN1CMA1XIAPACE | |
| SCHEMBL27913508 | 0.82 | CAPN1 (0.46) | GRB2CAPN1CTSBACEREN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111603567-B | CD44 targeted multi-arm conjugates | 赣江新区博瑞创新医药有限公司 | 2024-12-27 | — | — | CN | disclosed |